Stage TA-T1 bladder cancer: The relationship between findings at first followup cystoscopy and subsequent recurrence and progression

Sten Holmäng, Sonny L. Johansson

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Purpose: We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer. Materials and Methods: All 463 patients with an initial diagnosis of stage Ta-T1 bladder cancer in western Sweden in 1987 to 1988 were followed at least 5 years. The 355 patients who were treated with transurethral resection only until repeat cystoscopy or longer were selected for this report. Results: Negative first cystoscopy findings were associated with significantly decreased recurrence and progression rates for all grades, and for stage Ta and T1 tumors. However, some patients with initial high grade carcinoma (WHO 2 to 3) had stage progression despite negative first cystoscopy. On multivariate analyses first cystoscopy findings and papillary urothelial neoplasm of low malignant potential versus grades 1 to 3 but not stage and the number of tumors had prognostic significance for time to recurrence. Only first cystoscopy findings and grade had prognostic significance for time to stage progression. Conclusions: Our data support other groups who recommend a less intense cystoscopy followup schedule in patients with negative cystoscopy findings 3 months after initial transurethral bladder resection. We recommend that patients with initial papillary urothelial neoplasm of low malignant potential and low grade carcinoma (WHO 1) with negative first cystoscopy findings undergo repeat cystoscopy at month 12. In our opinion followup should not be less intense in patients with high grade carcinoma (WHO 2-3), even in those with stage pTa disease.

Original languageEnglish (US)
Pages (from-to)1634-1637
Number of pages4
JournalJournal of Urology
Volume167
Issue number4 I
DOIs
StatePublished - Jan 1 2002

Fingerprint

Cystoscopy
Urinary Bladder Neoplasms
Recurrence
Carcinoma
Neoplasms
Sweden
Appointments and Schedules
Urinary Bladder
Multivariate Analysis

Keywords

  • Bladder
  • Bladder neoplasms
  • Cystoscopy
  • Disease progression
  • Recurrence

ASJC Scopus subject areas

  • Urology

Cite this

Stage TA-T1 bladder cancer : The relationship between findings at first followup cystoscopy and subsequent recurrence and progression. / Holmäng, Sten; Johansson, Sonny L.

In: Journal of Urology, Vol. 167, No. 4 I, 01.01.2002, p. 1634-1637.

Research output: Contribution to journalArticle

@article{c89c41c2ba9c4e9e989ab058d1f7f61e,
title = "Stage TA-T1 bladder cancer: The relationship between findings at first followup cystoscopy and subsequent recurrence and progression",
abstract = "Purpose: We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer. Materials and Methods: All 463 patients with an initial diagnosis of stage Ta-T1 bladder cancer in western Sweden in 1987 to 1988 were followed at least 5 years. The 355 patients who were treated with transurethral resection only until repeat cystoscopy or longer were selected for this report. Results: Negative first cystoscopy findings were associated with significantly decreased recurrence and progression rates for all grades, and for stage Ta and T1 tumors. However, some patients with initial high grade carcinoma (WHO 2 to 3) had stage progression despite negative first cystoscopy. On multivariate analyses first cystoscopy findings and papillary urothelial neoplasm of low malignant potential versus grades 1 to 3 but not stage and the number of tumors had prognostic significance for time to recurrence. Only first cystoscopy findings and grade had prognostic significance for time to stage progression. Conclusions: Our data support other groups who recommend a less intense cystoscopy followup schedule in patients with negative cystoscopy findings 3 months after initial transurethral bladder resection. We recommend that patients with initial papillary urothelial neoplasm of low malignant potential and low grade carcinoma (WHO 1) with negative first cystoscopy findings undergo repeat cystoscopy at month 12. In our opinion followup should not be less intense in patients with high grade carcinoma (WHO 2-3), even in those with stage pTa disease.",
keywords = "Bladder, Bladder neoplasms, Cystoscopy, Disease progression, Recurrence",
author = "Sten Holm{\"a}ng and Johansson, {Sonny L.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(05)65168-3",
language = "English (US)",
volume = "167",
pages = "1634--1637",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4 I",

}

TY - JOUR

T1 - Stage TA-T1 bladder cancer

T2 - The relationship between findings at first followup cystoscopy and subsequent recurrence and progression

AU - Holmäng, Sten

AU - Johansson, Sonny L.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Purpose: We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer. Materials and Methods: All 463 patients with an initial diagnosis of stage Ta-T1 bladder cancer in western Sweden in 1987 to 1988 were followed at least 5 years. The 355 patients who were treated with transurethral resection only until repeat cystoscopy or longer were selected for this report. Results: Negative first cystoscopy findings were associated with significantly decreased recurrence and progression rates for all grades, and for stage Ta and T1 tumors. However, some patients with initial high grade carcinoma (WHO 2 to 3) had stage progression despite negative first cystoscopy. On multivariate analyses first cystoscopy findings and papillary urothelial neoplasm of low malignant potential versus grades 1 to 3 but not stage and the number of tumors had prognostic significance for time to recurrence. Only first cystoscopy findings and grade had prognostic significance for time to stage progression. Conclusions: Our data support other groups who recommend a less intense cystoscopy followup schedule in patients with negative cystoscopy findings 3 months after initial transurethral bladder resection. We recommend that patients with initial papillary urothelial neoplasm of low malignant potential and low grade carcinoma (WHO 1) with negative first cystoscopy findings undergo repeat cystoscopy at month 12. In our opinion followup should not be less intense in patients with high grade carcinoma (WHO 2-3), even in those with stage pTa disease.

AB - Purpose: We studied the relationship of first cystoscopy findings with recurrence and progression rates in a large, population based series of patients with bladder cancer. Materials and Methods: All 463 patients with an initial diagnosis of stage Ta-T1 bladder cancer in western Sweden in 1987 to 1988 were followed at least 5 years. The 355 patients who were treated with transurethral resection only until repeat cystoscopy or longer were selected for this report. Results: Negative first cystoscopy findings were associated with significantly decreased recurrence and progression rates for all grades, and for stage Ta and T1 tumors. However, some patients with initial high grade carcinoma (WHO 2 to 3) had stage progression despite negative first cystoscopy. On multivariate analyses first cystoscopy findings and papillary urothelial neoplasm of low malignant potential versus grades 1 to 3 but not stage and the number of tumors had prognostic significance for time to recurrence. Only first cystoscopy findings and grade had prognostic significance for time to stage progression. Conclusions: Our data support other groups who recommend a less intense cystoscopy followup schedule in patients with negative cystoscopy findings 3 months after initial transurethral bladder resection. We recommend that patients with initial papillary urothelial neoplasm of low malignant potential and low grade carcinoma (WHO 1) with negative first cystoscopy findings undergo repeat cystoscopy at month 12. In our opinion followup should not be less intense in patients with high grade carcinoma (WHO 2-3), even in those with stage pTa disease.

KW - Bladder

KW - Bladder neoplasms

KW - Cystoscopy

KW - Disease progression

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=0036128238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036128238&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(05)65168-3

DO - 10.1016/S0022-5347(05)65168-3

M3 - Article

C2 - 11912378

AN - SCOPUS:0036128238

VL - 167

SP - 1634

EP - 1637

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4 I

ER -